Add this topic to your myFT Digest for news straight to your inbox
GW Pharmaceuticals, Asian Citrus, Madagascar Oil and Telecom Plus featured
Investing in marijuana remains something of a pirates’ game
Allowing Aim shares into Isas has not been revolutionary for anyone
Can the UK sector overcome painful memories?
Skyrocketing company valuations have triggered regulatory alarms
Twenty companies raise $3.6bn through DR programmes in first half of 2013
Kevin Goldstein-Jackson fears a change of personnel in the White House
A fox and a robin teach me to seek out stock market rewards, says Kevin Goldstein-Jackson
Our columnists have a positive start to the year
My interest in GW pharmaceuticals has been reawakened, writes Kevin Goldstein-Jackson
International Edition